The World Health Organization will send thousands of doses of NewLink's experimental Ebola vaccine to West Africa in January. Dr. Charles Link, NewLink Genetics Chairman, CEO & Chief Scientific Officer, provides insight to supply capabilities, as well as the company's $1 billion deal with Roche.» Read More
Activist investor Jana Partners has been calling for fertilizer producer Agrium to break up into separate wholesale and retail businesses. Michael Wilson, Agrium president and CEO, says his company's stock is up and it has "nothing to do with Jana."
Breaking down Eli Lilly's solid Q4 earnings, and the company's outlook for 2013, with its CFO Derica Rice. "From a regulatory standpoint, we have really seen a harmonization between the U.S. and Europe," he says.
Nat Rothschild, Co-founder of Bumi stepped up the bitter battle for control of the Indonesia-focused miner, attacking both the board for its inaction and CEO Nick von Schirnding for "embellishing his CV."
Frans van Houten, CEO of Philips, tells CNBC about a deal announced with Funai which will reposition the Philips portfolio away from consumer electronics to be a company positioned in health and wellbeing.
Opko Health chairman and CEO Dr. Phillip Frost, offers insight on his company's acquisition of Cytochromas, its partnerships with companies like Bristol-Meyers Squibb, and where the company is headed this year.
Carter Cleveland, Art.sy founder & CEO, explains how his company is making the art world more accessible and easier to explore online.
David Cote, Chairman & CEO of Honeywell International, weighs in on his company's better-than-expected earnings and provides an outlook on the remainder of the year.
Doug Oberhelman, Caterpillar chairman & CEO, breaks down Caterpillar's fourth quarter numbers, and discusses his company's outlook amid political and global uncertainty.
In a candid conversation with Jim Cramer, CEO T.J. Rodgers explains the changes he's implemented at Cypress to goose the bottom line and potentially, the stock price.
Weyerhaeuser CEO Dan Fulton discusses log demand in Japan, the housing economy and how his company is working to build profits in 2013.
Juniper Networks CEO Kevin Johnson offers a 2013 outlook for his company, and discusses what a Dell buyout would mean for the tech industry.
David Lissy, Bright Horizons Family Solutions CEO, discusses his company's initial public offering today on the Nasdaq.
CNBC's Andrew Ross Sorkin sits down with Lloyd Blankfein,Goldman Sachs chairman & CEO, at the World Economic Forum in Davos, Switzerland, to discuss the impact of regulations on banking and the outlook on M&A activity in the coming year.
CNBC's Andrew Ross Sorkin sits down with Lloyd Blankfein,Goldman Sachs chairman & CEO, at the World Economic Forum in Davos, Switzerland, to discuss the global economic outlook. The U.S. economic environment is "very good," he said.
Thomas Falk, Kimberly-Clark chairman & CEO, breaks down the household products makers fourth quarter earnings, and discusses growth opportunities in China, and commodity headwinds.
Avnet CEO Rick Hamada offers insight on his company's quarterly results, and what it means for the technology industry.
The Timken Company president & CEO Jim Griffeth, discusses the year ahead for his company, and how the growth of the domestic natural gas market is driving profitability.
Jonathan Litt, Land & Buildings founder & CEO, explains why investors could see more publicly traded railroads converting into real estate investment trusts. "We think there are a lot of compelling opportunities for conversions," he says.
Discussing Netflix's best day in more than a decade, with the Fast Money traders; and Verifone CEO Doug Bergeron discusses rising competition in mobile payments.
Watson Pharmaceuticals has merged with Actavis, and will now trade on the NYSE under ticker symbol ACT. Its president & CEO Paul Bisaro, discusses the U.S. economy and the generic drug industry.